Evidence map›Paper›PMID 34666728›Full record

Trial reportBMC urology2021

Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial.

Nikan Zerafatjou, Mohammadali Amirzargar, Mahdi Biglarkhani, Farzaneh Shobeirian, Ghazal Zoghi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Profiling HydrophilicPlants (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nikan ZerafatjouDepartment of Urology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. nikan.zerafatjou@gmail.com.ORCID http://orcid.org/0000-0002-3110-2830
Mohammadali AmirzargarUrology and Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Mahdi BiglarkhaniDepartment of Persian Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Farzaneh ShobeirianDepartment of Radiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Ghazal ZoghiEndocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Hamedan University of Medical Sciences · IRGuilan University of Medical Sciences · IRHormozgan University of Medical Sciences · IR

Funding

Hamadan University of Medical Sciences IR.UMSHA.REC.1398.429
6 · The paper itself

Abstract

backgroundBenign prostatic hyperplasia (BPH) is very common in aging men. We aimed to compare the effects of tamsulosin and pumpkin (Cucurbita pepo) seed oil on BPH symptoms.

methodsThis single-blind randomized clinical trial included patients with BPH aged ≥ 50 years referred to the Urology Clinic of Shahid Beheshti Hospital, Hamadan, Iran, from August 23, 2019 to February 19, 2020. Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg pumpkin seed oil twice a day. Patients' age, weight, height, and body mass index (BMI) were recorded. The International Prostate Symptom Score (IPSS) was filled out by the patients at baseline and then 1 month and 3 months after the initiation of treatment. The BPH-associated quality of life (QoL), serum prostate-specific antigen, prostate and postvoid residual volume, and maximum urine flow were also assessed at baseline and 3 months later. Drug side effects were also noted.

resultsOf the 73 patients included in this study with a mean age of 63.59 ± 7.04 years, 34 were in the tamsulosin group and 39 in the pupkin seed oil group. Patients were comparable with respect to age, weight, height, BMI, and baseline principal variables in both groups. Also, there was no significant difference between groups in terms of principal variables at any time point. However, there was a significant decrease in IPSS and a significant improvement in QoL in both groups. Although the decrease in IPSS from baseline to 1 month and 3 months was significantly higher in the tamsulosin group compared to the pumpkin group (P = 0.048 and P = 0.020, respectively), the decrease in IPSS from 1 to 3 months was similar (P = 0.728). None of the patients in the pumpkin group experienced drug side effects, while dizziness (5.9%), headache (2.9%), retrograde ejaculation (2.9%), and erythema with pruritus occurred in the tamsulosin group.

conclusionsPumpkin (Cucurbita pepo) seed oil relieved BPH symptoms with no side effects, but was not as effective as tamsulosin. Further studies are required to confirm the role of pumpkin seed oil as an option for the treatment of BPH symptoms. Trial registration Iranian Registry of Clinical Trials, IRCT20120215009014N340. Registered 19.02.2020. Retrospectively registered, https://en.irct.ir/trial/45335 .

Indexed as

CucurbitaAgedHumansIranKallikreinsMaleMiddle AgedPlant OilsProstate-Specific AntigenProstatic HyperplasiaQuality of LifeSingle-Blind MethodTamsulosinUrinationUrological AgentsKallikreinsKLK3 protein, humanPlant OilsProstate-Specific AntigenTamsulosinUrological AgentsBenign prostatic hyperplasiaPumpkin seed oilTamsulosin

Identifiers

PMID34666728
PMCPMC8527717
OpenAlexW3207779471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.